An alternating chemotherapy combination
โ
M. Harding; L. McNulty; J. Paul; F. Lee; D. Dunlop; M. Soukop
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 485 KB
๐ 1 views
48 patients with intermediate or high-grade non-Hodgkin's lymphomas (NHL) received a CHOP based combination with the addition of etoposide on days 1 and 2, bleomycin days 1 and 10 and methotrexate 1.5 g/m2 on day 10 (MACOBLE). Their median age was 59 years, 20 (42 per cent) had an ECOG performance s